Skip to main content
. 2022 Jun 25:10.1002/eat.23765. Online ahead of print. doi: 10.1002/eat.23765

FIGURE 2.

FIGURE 2

Observed mean percentage change from baseline to end of treatment and 20‐week follow‐up in body mass index (BMI), eating disorder examination questionnaire (EDE‐Q), clinical impairment assessment (CIA) and brief symptom inventory (BSI) scores in completers patients with anorexia nervosa treated during versus before the COVID‐19 pandemic.